To be able to investigate tumour heterogeneity with respect to oncogene expression, we applied padlock probe rolling circle amplification to indentify EGFR, MET and the whole-exon deletion splice variants of these oncogenes that play a role in, among others, glioma and NSCLC1,5,16,29–31. The gene discussed is MET; the disease is central nervous system cancer.